Companies Companies
Results, guidance and the boardroom
More from Companies
Companies 
Companies Yum! Brands Insider’s 28% Stake Cut Was Tax Withholding, Not a Sale
A Yum Brands insider stake cut of 28% looks dramatic on paper, but the filing shows routine RSU tax withholding, not an option exercise.
Companies CoreWeave’s Hudson River Trading deal fuels Nvidia chip race
CoreWeave's Hudson River Trading deal deepens the scramble for Nvidia chips, even as the AI cloud group's quarterly losses keep widening.
Business Aconomy Card: The Payment Card Bringing Real-World Utility to Digital Assets
Dubai, UAE - 20 Aug 2026: For years, the crypto industry has talked about mainstream adoption without fully solving one of its most basic problems: how do you actually spend…
Companies Planet Labs Growth Stock Makes the Case Against SpaceX’s Valuation
Planet Labs PBC (NYSE: PL), the Earth-observation satellite operator, is one of five growth stocks currently trading more than 50% below their consensus analyst price targets, placing it in the…
Companies SpaceX Stock IPO Craters Over 50% from Peak as Loss-Making Reality Bites
The SpaceX stock IPO, priced at $135 per share on 11 June 2026, has delivered a brutal lesson in the distance between narrative and fundamentals. From an intraday peak above…
Companies How to Set a SIPP Retirement Income Target That Matches the State Pension
The new State Pension pays £12,547 a year, and setting a SIPP retirement income target of the same figure is one of the more useful ways to frame what a…
Companies Hays Shares Recovery Powers 64.5% Gain as Profit Guidance Hits Top End
The Hays shares recovery has been one of the more arresting moves in the UK mid-cap space this summer, with HAS climbing 64.5% over the past month after a trading…
Companies Marvell Google Chip Deal: Shares Jump ~11% on $12.2bn Warrant
The Marvell Google chip deal hands Alphabet a warrant worth up to $12.2bn - but most of it only vests if Google actually buys the chips.
Companies Novo Nordisk Tests Lower-Dose Wegovy Pill in 450-Patient Study
Novo Nordisk has begun testing a lower-dose Wegovy pill in a 450-patient study, a pipeline move that could reshape GLP-1 pricing and competition.
Markets How Rain Trade Is Opening Prediction Markets to More People
User-created markets are changing who gets to decide what people can predict.
Companies Lloyds Banking Group Shares Hold Their Case After a 43% Run
Lloyds Banking Group shares have climbed 43% over the past twelve months, crossed the £1 mark for the first time in nearly two decades, and pushed the bank's market capitalisation…
Companies SpaceX Share Price Recovers from 52% Plunge, but the Lockup Flood Runs to Mid-2027
The SpaceX share price has recovered 35% in five sessions after the company passed its first insider lockup test, clawing back above the $135 IPO price — but SPCX shareholders…
Companies What a £20,000 FTSE 100 Tracker ISA from the 2020 Crash Would Be Worth Today
A £20,000 FTSE 100 tracker ISA opened at the market low of March 2020 would now be worth around £38,200, based on the index's 91% capital gain since that point.…
Companies Labcorp NACHC alliance to back health centre leaders
The Labcorp NACHC alliance pairs diagnostics data with leadership training for 1,526 US community health centres serving 52.3m patients.
Companies Rocket Lab Share Price Slides 57%: What UK Investors Need to Know
The Rocket Lab share price has retreated from a peak of $150 to $65 in the space of two months, a fall of 57% that has brought RKLB back within…
Companies Concurrent Technologies Shares Reveal Record Order Book Ahead of Any FTSE Pullback
Concurrent Technologies shares are drawing fresh attention from small-cap watchers after the AIM-listed defence and aerospace computing specialist posted a half-year trading update that underlines just how sharply its order…
Markets HCA Healthcare Quarterly Earnings Beat Wall Street — But the Fine Print Tells a Different Story
There's a certain rhythm to how HCA Healthcare reports earnings. The Nashville-based hospital giant drops its numbers, beats estimates, and the stock moves modestly one way or the other. Q2…
Companies Amazon AWS Q2 Results Silence AI Bubble Fears After 15% Share Surge
Amazon AWS Q2 results have forced a reassessment of one of the market's most persistent anxieties: whether the hundreds of billions being poured into artificial intelligence infrastructure will ever yield…
Companies British American Tobacco Dividend Yields 5.4%, But Can It Fund a £6,622 Second Income?
The British American Tobacco dividend, currently yielding 5.4% on the London Stock Exchange, sits at the centre of a straightforward compounding thesis: invest £500 a month, reinvest the income for…
Companies Sunday Money: Nebius Group shares surge caps a blistering week
Sunday Money: Nebius Group shares surge 46.6% leads a wild week for markets, plus Sandisk, Tapestry, crypto and the numbers that mattered.
Companies Diageo Shares Turnaround Tests the Patience of Value Investors
The Diageo shares turnaround thesis rests on a familiar template: a world-class franchise, temporarily unloved, trading at a discount that rewards those willing to wait. Warren Buffett applied exactly that…
Companies Amitabh Bachchan Ayodhya Land Investment Crosses ₹90 Crore — And He’s Still Not Done
The way Amitabh Bachchan allegedly made his most talked-about real estate move is telling. Not after months of discussion, not thru a property manager, not during a board meeting—rather, it…
Companies